SCHEMBL10077353

SCHEMBL10077353

CCCCC/C=C/C/C=C/C/C=C/C/C=C/CCCC(=O)n1c(C)c(CC(=O)O)c2cc(OC)ccc21

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AKR1C3 P42330 6/20 0.57
AKR1C2 P52895 6/20 0.57
LMNA P02545 2/20 0.56
CYP1A2 P05177 2/20 0.56
CYP2D6 P10635 2/20 0.56
CYP2C9 P11712 2/20 0.56
HIF1A Q16665 2/20 0.56
NPSR1 Q6W5P4 2/20 0.56
TSHR P16473 1/20 0.56
NFKB1 P19838 1/20 0.56
PTGS2 P35354 2/20 0.53
AKR1C4 P17516 2/20 0.53
AKR1C1 Q04828 2/20 0.53
KDM4E B2RXH2 1/20 0.53
MEN1 O00255 1/20 0.53
PTGES O14684 1/20 0.53
ABCC3 O15438 1/20 0.53
ABCC4 O15439 1/20 0.53
ABCB11 O95342 1/20 0.53
MT-CO2 P00403 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL469467 0.98 AKR1C3 (0.57) AKR1C3AKR1C2LMNACYP1A2CYP2D6
SCHEMBL469584 0.97 AKR1C3 (0.56) AKR1C3AKR1C2LMNACYP1A2CYP2D6
SCHEMBL469506 0.95 AKR1C3 (0.58) AKR1C3AKR1C2LMNACYP1A2CYP2D6
SCHEMBL469475 0.93 AKR1C3 (0.58) AKR1C3AKR1C2LMNACYP1A2CYP2D6
SCHEMBL456875 0.87 AKR1C3 (0.60) AKR1C3AKR1C2LMNACYP1A2CYP2D6
SCHEMBL456876 0.87 AKR1C3 (0.60) AKR1C3AKR1C2LMNACYP1A2CYP2D6
SCHEMBL8649132 0.77 LMNA (0.69) AKR1C3AKR1C2LMNACYP1A2CYP2D6
SCHEMBL9235971 0.76 PTGS2 (0.74) AKR1C3AKR1C2LMNACYP1A2CYP2D6
SCHEMBL10876035 0.76 AKR1C3 (0.76) AKR1C3AKR1C2LMNACYP1A2CYP2D6
SCHEMBL18271385 0.75 AKR1C3 (0.82) AKR1C3AKR1C2LMNACYP1A2CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20160120995-A1 CONJUGATES OF POLYUNSATURATED FATTY ACIDS AND AMINE-CONTAINING COMPOUNDS AND USES THEREOF MEDWELL LAB LTD (IL) 2016-05-05 US disclosed
US-20160120995-A1 CONJUGATES OF POLYUNSATURATED FATTY ACIDS AND AMINE-CONTAINING COMPOUNDS AND USES THEREOF MEDWELL LAB LTD (IL) 2016-05-05 US disclosed
US-20130158070-A1 CONJUGATES OF POLYUNSATURATED FATTY ACIDS AND AMINE-CONTAINING COMPOUNDS AND USES THEREOF MEDWELL LABORATORIES LTD. (IL) 2013-06-20 US disclosed
US-20130158070-A1 CONJUGATES OF POLYUNSATURATED FATTY ACIDS AND AMINE-CONTAINING COMPOUNDS AND USES THEREOF MEDWELL LABORATORIES LTD. (IL) 2013-06-20 US disclosed
WO-2012032509-A2 CONJUGATES OF POLYUNSATURATED FATTY ACIDS AND AMINE-CONTAINING COMPOUNDS AND USES THEREOF MEDWELL LABORATORIES LTD. (IL) 2012-03-15 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130158070-A1 CONJUGATES OF POLYUNSATURATED FATTY ACIDS AND AMINE-CONTAINING COMPOUNDS AND USES THEREOF ALOX5, ALOX15B, ALOX15 AKR1C3 888/4885AKR1C2 1177/4885LMNA 3256/4885
US-20160120995-A1 CONJUGATES OF POLYUNSATURATED FATTY ACIDS AND AMINE-CONTAINING COMPOUNDS AND USES THEREOF ALOX5, ALOX15B, ALOX15 AKR1C3 918/4885AKR1C2 1219/4885LMNA 3566/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.